Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 KBI Biopharma Names JB Agnus as Chief Business Officer | Contract Pharma

What are you searching for?

Sign in
Breaking News

KBI Biopharma Names JB Agnus as Chief Business Officer

Agnus brings more than two decades of experience across various sectors of the biopharmaceutical industry.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

KBI Biopharma Inc., a JSR Life Sciences company and global cGMP contract development and manufacturing organization (CDMO), has appointed Jean-Baptiste (JB) Agnus as its Chief Business Officer.
 
Agnus brings more than two decades of experience across various sectors of the biopharmaceutical industry with expertise in commercial development in biologics, small molecule APIs, antibody-drug conjugates (ADCs), and the latest advancements in cell and gene therapies. Agnus will lead KBI’s global business development initiatives to drive the company toward continued growth and sustained success. This role is focused on building and maintaining long-lasting partnerships with KBI’s current and future customers around the globe.
 
Before joining KBI, Agnus held leadership roles in business development at AGC Biologics, Ajinomoto Bio-Pharma Services, Novasep, and Isochem. He holds a Master of Science in Chemical Engineering from Centrale Marseille.
 
“Our dedication to growth and commitment to our partners, their patients, and our people guide every decision at KBI Biopharma,” remarked J.D. Mowery, President & CEO of KBI Biopharma. “JB’s appointment underscores this dedication, perfectly aligning with our team’s mission to deliver innovative, top-tier solutions tailored to our customers’ evolving needs. His servant leadership philosophy will further fortify our team, propelling KBI to new heights.”
 
“KBI Biopharma is an innovator in the testing, development, manufacturing, and commercialization of life-changing therapies,” said Agnus. “Strong partnerships are at the core of KBI’s success. I am excited to join the passionate team at KBI, who are committed to ensuring transformative treatments reach those in need by nurturing meaningful customer relationships.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics